Andras Sikter¹* and Christian Sonne²

¹Department of Internal Medicine, Municipal Clinic of Szentendre, Hungary
²Department of Bioscience, Aarhus University, Arctic Research Centre (ARC), Denmark

*Corresponding Author: Andras Sikter, Department of Internal Medicine, Municipal Clinic of Szentendre, Hungary.

Received:June 15, 2021; Published: July 14, 2021

Citation: Andras Sikter and Christian Sonne. “Is the Primary Aetiology of Hypertension Unknown? Novel Views on Previous Assumptions". Acta Scientific Microbiology 5.8 (2021): 47-53.

Abstract

Most details of primary hypertension are known, however, it is still unclear how and why the increased activity of angiotensin II and aldosterone cause developing primary hypertension seen worldwide. Here we hypothesize that primary hypertension is an age-related disease initiated by the acidification of the intracellular milieu. The renin-angiotensin-aldosterone system (RAAS), like many other hormones, work through feedback mechanisms, with aldosterone restoring pH and electrolyte changes produced by respiratory acidosis in targeted cardiovascular and kidney cells. High NaCl intake enhances the effect of aldosterone (salt-sensitive hypertension). By contrast, angiotensin II restores H⁺ and electrolyte abnormalities caused by metabolic acidosis in the targeted cells (salt-resistant hypertension). Aldosterone and angiotensin II decrease H⁺ concentration synergistically, but act antagonistically on Cl^- to HCO₃^- concentrations. However, both hormones overcompensate acidosis and increase Na⁺ retention leading to increased circulatory resistance, hypertension, and left-heart hypertrophy by a cascade of events. If this hypothesis is true, the cause of essential hypertension is chronic respiratory and metabolic acidosis and RAAS activation. Preventing age-related intracellular acidosis through a non-hormonal way could prevent pathophysiological blood pressure elevation. It is a challenge to mitigate pCO₂ level permanently and we, therefore, recommend a salt mixture of KH₂PO₄ and other Mg²⁺, K⁺, Ca²⁺ and phosphate salts to relieve the withdrawal symptoms in hypercapnia.

Keywords: Intracellular Acidosis; RAAS as a Feedback Mechanism; Salt-resistant Hypertension; Salt-Sensitive Hypertension; Weaning from Hypercapnia

Bibliography

1. Rosskopf D., et al. “Membrane sodium-proton exchange and primary hypertension”. 21.5 (1993): 607-617.
2. Chipperfield AB and Harper AA. “Chloride is smooth muscle”. Progress in Biophysics and Molecular Biology 3-5 (2000): 175-221.
3. Ng HY., et al. “Activation of intrarenal renin-angiotensin system during metabolic acidosis”. American Journal of Nephrology1 (2011): 55-63.
4. Wesson DE., et al. “Acid retention accompanies reduced GFR in humans and increases plasma levels of endothelin and aldosterone”. American Journal of Physiology - Renal Physiology 4 (2011): F830-837.
5. Charles L., et al. “Secondary Hypertension: Discovering the Underlying Cause”. American Family Physician7 (2017): 453-461.
6. Carretero OA and Oparil S. “Essential hypertension. Part I: definition and etiology”. Circulation3 (2000): 329-335.
7. Aryal D., et al. “Chronic metabolic acidosis elicits hypertension via upregulation of intrarenal angiotensin II and induction of oxidative stress”. Antioxidants Basel 1 (2021): 2.
8. Boedtkjer E and Aalkjaer C. “Disturbed acid-base transport: an emerging cause of hypertension”. Frontiers in Physiology 4 (2013): 388.
9. Anderson DE. “Cardiorenal effects of behavioral inhibition of breathing”. Biological Psychology 1-2 (1998): 151-163.
10. Sikter A and Sonne C. “A new hypothesis on vascular calcification: the exhausting buffer syndrome (EBS)”. Neuropsychopharmacology Hung1 (2021): 215-220.
11. Choi HY., et al. “Salt sensitivity and hypertension: a paradigm shift from kidney malfunction to vascular endothelial dysfunction”. Electrolyte Blood Press1 (2015): 7-16.
12. Satoh M., et al. “Aldosterone-to-renin ratio and nocturnal blood pressure decline assessed by self-measurement of blood pressure at home: the Ohasama Study”. Clinical and Experimental Hypertension 2 (2014): 108-114.
13. Fujita T. “Mechanism of salt-sensitive hypertension: focus on adrenal and sympathetic nervous systems”. Journal of the American Society of Nephrology 6 (2014): 1148-1155.
14. Snyder EM., et al. “Arg16Gly polymorphism of the beta2-adrenergic receptor is associated with differences in cardiovascular function at rest and during exercise in humans”. Journal of Physiology1 (2006): 121-130.
15. Pojoga L., et al. “Beta-2 adrenergic receptor diplotype defines a subset of salt-sensitive hypertension”. Hypertension5 (2006): 892-900.
16. Anderson DE., et al. “Salt sensitivity of blood pressure is accompanied by slow respiratory rate: results of a clinical feeding study”. Journal of the American Society of Hypertension 4 (2007): 256-263.
17. Williams GH and Hollenberg NK. “Non-modulating hypertension. A subset of sodium-sensitive hypertension”. Hypertension1 (1991): I81-185.
18. Chapman CL., et al. “Renal and segmental artery hemodynamic response to acute, mild hypercapnia”. American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 4 (2020): 822-R827.
19. Valli G., et al. “Water and sodium imbalance in COPD patients”. Monaldi Archives for Chest Disease 2 (2004): 112-116.
20. Relman AS. “Metabolic consequences of acid-base disorders”. Kidney International 1 (1972): 347-359.
21. Balnis J., et al. “Hypercapnia-Driven Skeletal Muscle Dysfunction in an Animal Model of Pulmonary Emphysema Suggests a Complex Phenotype”. Frontiers in Physiology 11 (2020): 600290.
22. Rocchini AP. “Obesity hypertension, salt sensitivity and insulin resistance”. Nutrition, Metabolism and Cardiovascular Diseases 5 (2000): 287-294.
23. Pimenta E., et al. “Increased dietary sodium is related to severity of obstructive sleep apnea in patients with resistant hypertension and hyperaldosteronism”. Chest4 (2013): 978-983.
24. Bruton A and Holgate ST. “Hypocapnia and asthma. A mechanism for breathing retraining?” Chest 127 (2005): 1808-1811.
25. Frassetto L and Sebastian A. “Age and systemic acid-base equilibrium: analysis of published data”. Journals of Gerontology Series A Biological Sciences and Medical Sciences 1 (1996): B91-99.
26. Dhokalia A., et al. “Resting end-tidal CO2 association with age, gender, and personality”. Psychosomatic Medicine 1 (1998): 33-37.
27. Anderson DE., et al. “Racial differences in resting end-tidal CO₂ and circulating sodium pump inhibitor”. American Journal of Hypertension 8 (2001): 761-767.
28. Anderson DE. “Respiratory psychophysiology in hypertension research”. Behavior modification 4 (2001): 606-620.
29. Pimenta E., et al. “Salt, aldosterone and hypertension”. Journal of Human Hypertension 1 (2013): 1-6.
30. Whaley-Connell A., et al. “Aldosterone: role in the cardiometabolic syndrome and resistant hypertension”. Progress in Cardiovascular Diseases5 (2010): 401-409.
31. Chipperfield AB, and Harper AA. “Chloride is smooth muscle”. Progress in Biophysics and Molecular Biology 3-5 (2000): 175-221.
32. Feldman M and Dickson B. “Adjusted Plasma Chloride and Bicarbonate Concentrations: An Approach to Identifying Acid-Base Disorders”. Journal of Applied Laboratory Medicine 6 (2018): 833-840.
33. Resnick LM., et al. “Intracellular pH in human and experimental hypertension”. Proceedings of the National Academy of Sciences of the United States of America 21 (1987): 7663-7667.
34. Wagner CA. “Effect of mineralocorticoids on acid-base balance”. Nephron Physiology1-2 (2014): 26-34.
35. Zhou Y., et al. “Effects of angiotensin II on the CO2 dependence of HCO3- reabsorption by the rabbit S2 renal proximal tubule”. American Journal of Physiology - Renal Physiology 3 (2006): F666-673.
36. Fogo AB. “Mechanisms of progression of chronic kidney disease”. Pediatric Nephrology12 (2007): 2011-2022.
37. Bidani AK and Griffin KA. “Pathophysiology of hypertensive renal damage: implications for therapy”. Hypertension 5 (2004): 595-601.
38. Wesson DE., et al. “Mechanisms of Metabolic Acidosis-Induced Kidney Injury in Chronic Kidney Disease”. Journal of the American Society of Nephrology 3 (2020): 469-482.
39. Wesson DE. “Is NaHCO3 an antiaging elixir?” American Journal of Physiology - Renal Physiology 1 (2016): F182-F183.
40. Melamed ML and Raphael KL. “Metabolic Acidosis in CKD: A Review of Recent Findings”. Kidney Medicine2 (2021): 267-277.
41. Leibrock CB., et al. “Bicarbonate-sensitive calcification and lifespan of klotho-deficient mice”. American Journal of Physiology - Renal Physiology1 (2016): F102-F108.
42. Forni LG., et al. “The Janus faces of bicarbonate therapy in the ICU: not sure!” Intensive Care Medicine3 (2020): 522-524.
43. Nicholl DDM., et al. “Nocturnal hypoxemia severity influences the effect of CPAP therapy on renal renin-angiotensin-aldosterone system activity in humans with obstructive sleep apnea”. Sleep5 (2021): zsaa228.
44. Iftikhar IH., et al. “Effects of continuous positive airway pressure on blood pressure in patients with resistant hypertension and obstructive sleep apnea: a meta-analysis”. Journal of Hypertens12 (2014): 2341-2350.
45. Szulczewski MT. “Training of paced breathing at 0.1 Hz improves CO2 homeostasis and relaxation during a paced breathing task”. PLoS One6 (2019): e0218550.
46. Sikter A. “Psychosomatic Molecular Mechanisms of Metabolic Syndrome and Type 2 Diabetes. Part 1. A Theory for Modelizing the Cytoplasm and Diseases". Acta Scientific Medical Sciences 1 (2020): 124-140.
47. Zhao Y., et al. “Effect of hypophosphatemia on the withdrawal of mechanical ventilation in patients with acute exacerbations of chronic obstructive pulmonary disease”. Biomed Report4 (2016): 413-416.
48. Seyyedi J., et al. “Comparison of the Effect of Enteral Feeding through the Bolus and Continuous Methods on Serum Phosphorus and Glucose Levels in Patients with Mechanical Ventilation: A Randomized Clinical Trial”. Journal of Nutrition and Metabolism (2020): 6428418.
49. Frisch LS and Mimouni F. “Hypomagnesemia following correction of metabolic acidosis: a case of hungry bones”. Journal of the American College of Nutrition6 (1993): 710-713.
50. Sikter A. “Psychosomatic Molecular Mechanisms of Metabolic Syndrome and Type 2 Diabetes. Part 4. A Recovery Strategy from Chronic Hypercapnia and Metabolic Syndrome-Related Disorders, (a Research Proposal)". Acta Scientific Medical Sciences3 (2020): 150-161.

Copyright: © 2021 Andras Sikter and Christian Sonne. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.